Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' TUASON L' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. BUDD GT; ADAMSON PC; GUPTA M; HOMAYOUN P; SANDSTROM SK; MURPHY RF; MCLAIN D; TUASON L; PEEREBOOM D; BUKOWSKI RM; GANAPATHI R
      PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/

      Clinical cancer research
    2. BUDD GT; ADAMSON PC; GUPTA M; HOMAYOUN P; SANDSTROM SK; MURPHY RF; MCLAIN D; TUASON L; PEEREBOOM D; BUKOWSKI RM; GANAPATHI R
      PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/

      Clinical cancer research
    3. KLEIN EA; KUPELIAN PA; TUASON L; LEVIN HS
      INITIAL DISSECTION OF THE LATERAL FASCIA REDUCES THE POSITIVE MARGIN RATE IN RADICAL PROSTATECTOMY

      Urology
    4. BUKOWSKI RM; OLENCKI T; WANG Q; PEEREBOOM D; BUDD GT; ELSON P; SANDSTROM K; TUASON L; RAYMAN P; TUBBS R; MCLAIN D; KLEIN E; NOVICK A; FINKE J
      PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN PATIENTS WITHRENAL-CELL CARCINOMA - CLINICAL-RESULTS AND IMMUNOLOGICAL CORRELATES OF RESPONSE

      Journal of immunotherapy with emphasis on tumor immunology
    5. SHANFELD RL; EDELMAN J; WILLIS JE; TUASON L; GOLDBLUM JR
      IMMUNOHISTOCHEMICAL ANALYSIS OF NEURAL MARKERS IN PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMORS (PPNET) WITHOUT LIGHT-MICROSCOPIC EVIDENCE OFNEURAL DIFFERENTIATION

      Applied immunohistochemistry
    6. ADELSTEIN DJ; SAXTON JP; LAVERTU P; TUASON L; WOOD BG; WANAMAKER JR; ELIACHAR I; STROME M; VANKIRK MA
      A PHASE-III RANDOMIZED TRIAL COMPARING CONCURRENT CHEMOTHERAPY AND RADIOTHERAPY WITH RADIOTHERAPY ALONE IN RESECTABLE STAGE-III AND STAGE-IV SQUAMOUS-CELL HEAD AND NECK-CANCER - PRELIMINARY-RESULTS

      Head & neck
    7. CAMISA C; PANZARELLA K; TUASON L
      TREATMENT OF 22 PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA WITH EXTRACORPOREAL PHOTOPHERESIS

      Journal of investigative dermatology
    8. BUKOWSKI RM; OLENCKI T; GUNN H; MCLAIN D; BUDD GT; SANDSTROM K; TUASON L; REDOVAN C; RAYMAN P; TUBBS R; RESTA D; ELSON P; FINKE J
      PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS

      Clinical cancer research
    9. OLENCKI T; FINKE J; TUBBS R; TUASON L; GREENE T; MCLAIN D; SWANSON SJ; HERZOG P; STANLEY T; EDINGER M; BUDD GT; BUKOWSKI RM
      IMMUNOMODULATORY EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-4 IN PATIENTS WITH MALIGNANCY

      Journal of immunotherapy with emphasis on tumor immunology
    10. VARELLA D; TUASON L; PROFFITT MR; ESCALEIRA N; ALQUEZAR A; BUKOWSKI RM
      HIV-INFECTION AMONG BRAZILIAN TRANSVESTITES IN A PRISON POPULATION

      AIDS patient care
    11. DONNELLY S; TUASON L; WALSH D
      QUALITY-OF-LIFE (QOL) ASSESSMENT IN ADVANCED CANCER

      Journal of palliative care
    12. ADELSTEIN DJ; SAXTON JP; LAVERTU P; TUASON L; WOOD BG; WANAMAKER JR; ELIACHAR I; STROME M; VANKIRK MA
      CONCURRENT RADIATION AND CHEMOTHERAPY (CT) VERSUS (VS) RADIOTHERAPY (RT) ALONE IN RESECTABLE STAGE-III AND STAGE-IV SQUAMOUS-CELL DEAD AND NECK-CANCER (SCHNC) - A PHASE-III RANDOMIZED TRIAL

      Journal of clinical oncology
    13. WOS E; OLENCKI T; TUASON L; BUDD GT; PEEREBOOM D; SANDSTROM K; MCLAIN D; FINKE J; BUKOWSKI RM
      PHASE-II TRIAL OF SUBCUTANEOUSLY ADMINISTERED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

      Cancer
    14. ANDRISH S; HOELTGE G; TUASON L; LICHTIN A
      CLINICAL CHARACTERISTICS OF PATIENTS WITH 11Q23 CHROMOSOME ABNORMALITY

      Blood
    15. GEORGE R; HOELTGE G; TUASON L; LICHTIN A
      CLINICAL CHARACTERISTICS OF PATIENTS WITH TRISOMY-8 (+8)

      Blood
    16. KALAYCIOGLU ME; LICHTIN AE; ANDRESEN SW; TUASON L; BOLWELL BJ
      HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND OR PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE FOR METASTATIC BREAST-CANCER/

      American journal of clinical oncology
    17. KALAYCIOGLU M; KAVURU M; TUASON L; BOLWELL B
      EMPIRIC PREDNISONE THERAPY FOR PULMONARY TOXIC REACTION AFTER HIGH-DOSE CHEMOTHERAPY CONTAINING CARMUSTINE (BCNU)

      Chest
    18. TANDON R; TUASON L; HOELTGE G; LICHTIN A
      CLINICAL CHARACTERISTICS OF PATIENTS WITH 20Q-CHROMOSOME DELETION

      Blood
    19. BUKOWSKI RM; MURTHY SA; FINKE J; CAULFIELD MJ; TUBBS R; HERZOG P; STANLEY J; EDINGER M; TUASON L; MCLAIN D; BUDD GT; OLENCKI T; GANAPATHI R
      PHASE-I TRIAL OF CISPLATIN, WR-2721, AND THE MURINE MONOCLONAL-ANTIBODY R24 IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND BIOLOGIC EFFECTS

      Journal of immunotherapy with emphasis on tumor immunology
    20. FINKE JH; RAYMAN P; HART L; ALEXANDER JP; EDINGER MG; TUBBS RR; KLEIN E; TUASON L; BUKOWSKI RM
      CHARACTERIZATION OF TUMOR-INFILTRATING LYMPHOCYTE SUBSETS FROM HUMAN RENAL-CELL CARCINOMA - SPECIFIC REACTIVITY DEFINED BY CYTOTOXICITY, INTERFERON-GAMMA SECRETION, AND PROLIFERATION

      Journal of immunotherapy with emphasis on tumor immunology
    21. BUKOWSKI RM; BUDD GT; GIBBONS JA; BAUER RJ; CHILDS A; ANTAL J; FINKE J; TUASON L; LORENZI V; MCLAIN D; TUBBS R; EDINGER M; THOMASSEN MJ
      PHASE-I TRIAL OF SUBCUTANEOUS RECOMBINANT MACROPHAGE-COLONY-STIMULATING FACTOR - CLINICAL AND IMMUNOMODULATORY EFFECTS

      Journal of clinical oncology
    22. LICHT MR; KLEIN EA; TUASON L; LEVIN H
      IMPACT OF BLADDER NECK PRESERVATION DURING RADICAL PROSTATECTOMY ON CONTINENCE AND CANCER CONTROL

      Urology
    23. BUKOWSKI RM; OLENCKI T; MCLAIN D; TUASON L; BUDD GT; SANDSTROM K; RAYMAN P; GUNN H; LEVITT D; FINKE J
      PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT INTERLEUKIN-3 (RHIL-3) FOLLOWING SUBCUTANEOUS (SQ) ADMINISTRATION TO PATIENTS WITH REFRACTORY MALIGNANCIES

      Blood
    24. KALAYCIOGLU M; COPELAN E; AVALOS B; KLEIN J; LICHTIN A; ANDRESEN S; FISHLEDER A; TUASON L; BOLWELL B
      MAJOR ABO-INCOMPATIBLE ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER TREATMENT WITH BUSULFAN AND CYCLOPHOSPHAMIDE - DECREASED RISK OF LEUKEMIC RELAPSE

      Experimental hematology
    25. OLENCKI T; BUDD GT; MURTHY S; FINKE J; HERZOG P; MCLAIN D; TUBBS R; TUASON L; EDINGER M; LEVITT D; BUKOWSKI RM
      CYTOKINE GENE-EXPRESSION AND SECRETION - EFFECTS OF RHIL-6 IN CANCER-PATIENTS

      Blood
    26. WOS E; HOELTGE G; TUASON L; LICHTIN A
      CLINICAL AND LABORATORY ANALYSIS OF PATIENTS WITH DELETIONS OF PART OF CHROMOSOME-5Q

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 06:54:09